Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Landos Biopharma Inc | LABP | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
22.30 | 22.185 | 22.43 | 22.235 | 22.25 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
25/3/2024 | 07:31 | PRNUS | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
25/3/2024 | 07:30 | GLOBE | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
04/3/2024 | 15:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
04/3/2024 | 15:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 15:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
04/1/2024 | 07:05 | EDGAR2 | Form 8-K - Current report |
21/11/2023 | 07:08 | EDGAR2 | Form 8-K - Current report |
09/11/2023 | 07:22 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/11/2023 | 07:08 | EDGAR2 | Form 8-K - Current report |
21/9/2023 | 07:00 | EDGAR2 | Form 8-K - Current report |
14/9/2023 | 07:11 | EDGAR2 | Form 8-K - Current report |
09/8/2023 | 07:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/8/2023 | 07:12 | EDGAR2 | Form 8-K - Current report |